Mild Ulcerative Colitis

Drug	Drug Name	Drug Description
DB01014	Balsalazide	An aminosalicylate used to treat ulcerative colitis.
DB00244	Mesalazine	An aminosalicylate drug used to treat mild to moderate active ulcerative colitis and also to maintain remission once achieved.

Drug	Drug Name	Target	Type
DB01014	Balsalazide	Prostaglandin G/H synthase 1	target
DB01014	Balsalazide	Prostaglandin G/H synthase 2	target
DB01014	Balsalazide	Arachidonate 5-lipoxygenase	target
DB01014	Balsalazide	Peroxisome proliferator-activated receptor gamma	target
DB01014	Balsalazide	NADPH azoreductase	enzyme
DB00244	Mesalazine	Prostaglandin G/H synthase 1	target
DB00244	Mesalazine	Prostaglandin G/H synthase 2	target
DB00244	Mesalazine	Peroxisome proliferator-activated receptor gamma	target
DB00244	Mesalazine	Inhibitor of nuclear factor kappa-B kinase subunit alpha	target
DB00244	Mesalazine	Inhibitor of nuclear factor kappa-B kinase subunit beta	target
DB00244	Mesalazine	Arachidonate 5-lipoxygenase	target
DB00244	Mesalazine	Arylamine N-acetyltransferase 1	enzyme
DB00244	Mesalazine	Solute carrier organic anion transporter family member 1B1	transporter
DB00244	Mesalazine	Solute carrier organic anion transporter family member 1B3	transporter
DB00244	Mesalazine	Solute carrier organic anion transporter family member 2B1	transporter
DB00244	Mesalazine	Nitric oxide synthase, inducible	target

Drug	Drug Name	Phase	Status	Count